We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The bill requires drugmakers to submit reports to HHS no later than 30 days prior to increasing the price of a non-rare disease, non-vaccine drug that costs $100 or more per month or course of treatment. Read More
Rep. Mike Kelly (R-Pa.) has asked acting FDA Commissioner Ned Sharpless on why the FDA doesn’t consider insulin to be a complex generic drug — a change that would help boost competion and lower prices. Read More
Presidential hopeful Sen. Kamala Harris (D-Calif.) has released an in-depth proposal to help lower drug prices by allowing HHS to cap prices for prescription drugs that are sold for less in developed countries or drugs whose annual prices are raised by more than the cost of inflation. Read More